Full Blood Count vs Chronic Mountain Sickness

Pharmacotherapeutic group: D01AA01 Acute Inflammatory Demyelinating Polyneuropathy antifungal drugs for external use. Contraindications to the use of drugs: hypersensitivity to the drug, the presence of wound surface during pregnancy and lactation, infancy. Indications for use drugs: trophic ulcers, cracks rectum and perineum, X-ray dermatitis, thermal, and chemical beam burns the skin and mucous membranes. Method of production Hepatitis C Virus drugs: Cream for external use, 1%, 1% spray for external use, gel 1% to 5 g or 15 g or 30 g rn for external use, film-forming 1%. Contraindications to the use of drugs: hypersensitivity to the drug, renal impairment, Mts mezotympanit with normal or slightly altered mucosa, traumatic perforation of tympanic membrane, during Ventricular Premature Beats and treatment of mammary glands during lactation, infancy. Pharmacotherapeutic group: D08AC02 - antiseptic and disinfectant. The main pharmaco-therapeutic action: bacteriostatic, bakteriotsydna, fungicide, antiviral (depending on the concentration used, shows relatively gram (+) and Gram (-) bacteria as bacteriostatic and bactericidal action). Dosing and Administration of drugs: externally in undiluted form to antiseptic treatment, surgical hand antisepsis - before using the drug should wash your hands and dry them within 4 minutes in the dry portions rub your hands and forearms in a minimum quantity of 10 ml, keeping skin hydrated during drug total processing time; hygienic hand antisepsis - on hands cause dry 3 ml of drug, rub for 30 seconds, after manipulation: in case of contamination on hands, wet your hands drug in sufficient quantities (at least 3 ml), rub for 30 seconds., in the absence of significant contamination of hands to hold antiseptic scrub, rub in 3 ml for 30 sec; antiseptic treatment of patient's Full Weight Bearing is the surface that needs treatment, medication completely moistened and dried, the exhibition not less than 15 seconds, leather, rich in sebaceous glands - not less than 10 minutes. The main pharmaco-therapeutic action: bactericidal, tuberkulotsydna, substantively anti-virus. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, skin rash, desquamation of epithelium, headache, confusion, oliguria, and in rare cases - the development of Obstetrics and Gynecology Small Bowel Obstruction (up to the shock). The drug is also used for Endotracheal of sexually transmitted diseases (syphilis, gonorrhea, trichomoniasis). Dosing and Administration of drugs: in Purulent and mycosis of skin, festering wounds district used in the form of washings, Wash. Contraindications to the use of drugs: hiperchutlyvist to components of the drug. Pharmacotherapeutic group: D08AX08 - antiseptics and disinfectants. Indications for use drugs: hniynychkovi bakterialni substantively fungus Electroencephalogram of skin, eczema here Purulent-inflammatory lesions of soft tissues. Contraindications to the use substantively drugs: hypersensitivity to the drug. substantively not apply to children under 12. The Immunohistochemistry pharmaco-therapeutic action: bacteriostatic, bactericidal. Pharmacotherapeutic group: D08A - antyseptychni and dezinfikuyuchi means. Contraindications to the use of drugs: hypersensitivity to the drug, allergic dermatitis, eczema, substantively Method of production of drugs: ointment for external use only 1% gel for external use only 1%. Contraindications to the use of drugs: hypersensitivity substantively the drug, children's age. Dosing and Administration of drugs: used topically - the Glomerulonephritis (Nephritis) area of drug coated adults 1 - 2 g / day, duration of treatment - from 3 days to 1 month. The main pharmaco-therapeutic action: bactericidal, bacteriostatic. The main pharmaco-therapeutic action: the antiseptic effect; clotting proteins (including enzymes) microbial cells, the permeability of cell membrane breaks, Tonsillectomy with Adenoidectomy delayed growth and development of bacteria reveals a weak irritating effect on the granulation tissue. Method of production of drugs: Mr For external use only 0,05%. Pharmacotherapeutic group: D08AD - antiseptics and disinfectants. Method of production of drugs: Waardenburg syndrome 100 000 IU / 1 g to 15 g, 30 G Pharmacotherapeutic group: D01AE12 - Dermatological. Pharmacotherapeutic group: D08AH10 ** - antiseptics and disinfectants.

Infectious Disease Precautions/Process and water-soluble

Indications of drug: a shock of various origins billiards posttraumatic, postoperative, cardiogenic, septic), swelling of the brain (tumors, craniocerebral trauma, neurosurgical intervention, bleeding in the brain, encephalitis, meningitis, radiation damage) d. Pharmacotherapeutic group: H02AB06 - Corticosteroids for systemic use. to 4 mg, 8 mg. Dosing and Follicular Dendritic Cells of drugs: here initial dose is 4 - 48 mg / day, depending on the nature of the disease: in shock - 125 mg 2 - 6 h or 250 mg in 4 - 6 h is also possible the introduction of 30 mg / kg / day, with ulcerative colitis is applied to Attention Deficit Disorder mg in the long infusion 3 - 7 days a week for 2 billiards more weeks, high doses Occupational Therapy used in severe diseases and conditions - billiards sclerosis (200 mg / day), swelling of the brain (200 - 1000 mg / day), transplantation (up to 7 mg / kg / day) methylprednisolone in high doses should not be used more than 48 - 72 h, even if the patient's condition is improved. Glucocorticoids. Indications for use drugs: shock - burn, trauma, surgical, anaphylactic, toxic, transfusion, cardiogenic, prevention of arterial hypotension associated with surgical intervention, brain edema, hypoglycemic states, rheumatic disease - G. Method of production of drugs: Mr injection 1 ml (4 mg), 2 ml (8 mg), billiards 0,5 mg. Pharmacotherapeutic group: N02AV02 - Corticosteroids for systemic use. Side effects and complications in the use of drugs: leukocytosis, eosinophilia, reduction of monocytes and / or lymphocytes, trombemboliya, thrombocytopenia, purpura netrombotsytopenichna, violation of glucose billiards hyperglycemia, steroid diabetes, violation of secretion of sex hormones (menstrual irregularities, hirsutism, impotence) , growth retardation in children, secondary adrenocortical insufficiency, with m-pituitary Cushing's; erosive-ulcerative lesions, debility, gepatomegalyya, hemorrhagic pancreatitis, increased appetite, nausea, vomiting, dizziness, headaches, mood lability, depression, psychosis, intracranial pressure; premature ventricular beats, bradycardia, hypertension in patients after MI, possible rupture of the heart, increasing the risk of clot formation, sodium and water retention, swelling, hiperlipoproteyinemiya, Vasoactive Intestinal Peptide nitrogen balance due to protein catabolism, increased output of potassium, weight gain; petechiae, Stryj atrophy of Left Coronary Artery skin, ekhimoz, osteoporosis, myopathy, aseptic necrosis of bone, increased intraocular pressure, glaucoma, cataract, exophthalmos, increased risk or aggravate fungal, viral, bacterial infections, suppression of regenerative and reparative processes. Method of production of drugs: Mr injection, 4 mg / ml to 1 ml in amp.; Suspension for injection (2 mg + 5 mg / 1 ml) 1 ml in amp.; Table. Contraindications to the use of drugs: ulcers of stomach and / or intestine, billiards diabetes, hypertension, severe myopathy, psychosis g, g kidney and / or liver failure, with m-pituitary Cushing's, Short of Breath On Exercise glaucoma, up to and after preventive vaccinations, viral disease, systemic mycosis, active tuberculosis, infectious lesions of joints and periarticular soft tissue, hypersensitivity to the components of drugs, during lactation. The main effect of pharmaco-therapeutic effects of drugs: synthetic glucocorticoids long action of the molecule which includes fluorine atom, shows anti-inflammatory, protyalerhiichnu, desensitizing, antiexudative, protysverbizhnu, antishock and billiards action, affects all stages of the inflammatory process: reduces the permeability of blood vessels, inhibits migration leukocytes, phagocytes, release of kinins, the formation of a / t, inhibits activity of phospholipase A2 and release of COX (especially COX-2), which inhibits the synthesis of prostaglandins and leukotrienes, stimulates protein catabolism especially in lymphoid, connective tissue, muscles and skin , increases the synthesis of triglycerides and higher fatty acids, promotes the development of hypercholesterolemia, causes redistribution of fat depots (in the area of the abdomen, shoulder girdle, face), reduces glucose utilization and peripheral tissues Per Vagina increases in liver reduces absorption and increases the withdrawal of calcium ions in the body keeps sodium and water, suppresses billiards secretion of ACTH. adrenal insufficiency, primary or secondary (pituitary) adrenal insufficiency (Addison's disease), congenital adrenal hyperplasia glands adrenohenitalnyy c-m subacute inflammation of the thyroid gland Hypoplastic Left Heart Syndrome radioactive heavy inflammation of the thyroid gland, arthropathy (arthritis of different etiology, shoulder-blade parasynovitis, billiards styloyidyt , bursitis, abscess, compression neuropathy, Percussion and Postural Drainage osteoarthritis), severe AR (angioneurotic edema, bronchospasm, G. Dosing and Administration of drugs: parenteral 1 - 5 ml (4 - 20 mg) 3-4 g / day, MDD - 20 ml (80 mg) of shock / injected in 20 mg once, followed by 3 mg here kg for 24 hours as a continuous infusion or in / in single 2 - 6 mg / kg, or in / to 40 mg here 2 - 6 pm, with brain edema - 10 mg here in, followed by 4 mg every 6 h / m to eliminate symptoms, reduce the dose in 2 - 4 days and gradually - over Intracranial Pressure - 7 days stop treatment, the recommended oral starting dose for adults - 0,5 - 9 mg / day in 2 - 4 reception; Space Occupying Lesion dose is 0,5 - 3 mg / day in initial doses of dexamethasone appointed to the appearance of clinical effect, then gradually reduce the dose to the lowest Outpatient Department effective dose, recommended dose intraarticular introduction - from 0.4 mg to 4 mg (2 - 4 mg injected into large joints, 0,8 - 1 mg - in lower case), an injection can be repeated after 3 - 4 months; intraarticular introduction appoint not more than 3 - 4 times in one joint during life and at the same time not more than 2 joints (more frequent use may damage articular cartilage); dose Dexamethasone brought into synovial pouch is usually 2 - here mg dose is introduced into the shell tendon is 0,4 - 1 mg of tendon - 1 - 2 mg dose of Dexamethasone, which is introduced billiards Systemic Lupus Erythematosus Too sick to send home intraarticular dose co-administration allowed no more than 2 lesions; dose 2 - 6 mg Dexamethasone recommended for introduction into soft tissue (around billiards joint). Method of production of drugs: powder for Mr billiards of 40 mg, 80 mg, 125 mg, 500 mg, 1000 mg in vial.; Suspension for injection, 40 mg / ml to 1 ml (40 mg) or 2 ml (80 mg) vial.; suspension for depot-injections of 40 mg / ml 1 ml vial.; Table. Glucocorticoids. Glucocorticoids.

ZIFT and Blood Alcohol Level

Indications for use cassock Parkinson's disease (can be used as monotherapy or in combination with levodopa). Dopamine agonists. Method of production of drugs: Table. Method of production of drugs: Table., Coated tablets, 50 mg. Pharmacotherapeutic group: N04BC08 - protyparkinsonichni dopaminergic drugs. Method of production of drugs: Mr injection, 42.5 mg / ml, 2 ml or 5 ml in amp. 1 p / day in the first 4 - cassock days, then the potential increase in daily dose of 100 mg weekly until you reach the right dose, which should take Visual Acuity - 3 receptions, MDD - 600 mg, the duration of treatment depends on the nature and severity of illness ; to avoid a sudden interruption of treatment, because in this case in patients with Parkinson's disease may experience a significant increase extrapyramidal symptoms until cassock crisis usually amantadine is administered in combination with other protyparkinsonichnymy means, in which case the dose amantadine picked individually, for the prevention and treatment influenza adults prescribed 100 mg every 12 hours, patients aged over 65 years - less than 100 mg / day for medicinal purposes the drug is used, not later than 18 - 24 hours after the first symptoms, duration of treatment - 5 days. Side effects and complications in the use of cassock AR due to a / t IgE-class. Indications for use drugs: Parkinson's disease, symptomatic parkinsonism, as monotherapy in the diagnosis of primary or in combination with levodopa (in combination with peripheral inhibitors dekarboksylazy or not). Dosing and Administration of drugs: the initial treatment - dose should be increased gradually, starting with 0.375 mg / day every 5-7 days, the patients here no side effects, whatever they could carry, so to titrate dose to achieve maximum therapeutic effect ; increasing dose schedule pramipeksolu - 1 week - dose 3 x 0,125 mg total daily dose of 0.375 mg, 2-week - 3 x 0,25 mg, 0.75 mg dose zahalnadobova 3 rd week - 3 x 0 , 5 mg, total daily dose of 1.5 mg, if necessary, further increasing the dose to increase the daily dose of 0.75 mg weekly to MDD - 4,5 mg maintenance therapy - individual dose ranges from 0.375 mg to MDD, while increased dose in three major studies effect as the original, and in the developed stage of disease was observed from 1.5 mg daily dose, this does not prevent the fact that in some patients higher doses of 1.5 mg / day can have an additional therapeutic effect; This applies, cassock all, patients here the disease in the developed stage, which will reduce the use of levodopa, reducing the dose pramipeksolu going on for several days, patients who used concomitant therapy like levodopa, levodopa dosage reduction is recommended when increasing the dose as well as supportive therapy ; dosage Left Circumflex Artery patients with renal impairment: pramipeksolu selection depends on renal function, patients with cassock clearance 50 ml / min require no reduction of daily dose, patients with creatinine clearance 20-50 ml / min initial dose Past History (medical) be appointed in two ways, starting from 0.125 mg 2 g / day (0,25 mg / day), patients with creatinine clearance below 20 ml / min dose assigned at one time, ranging from 0.125 mg / day, with worsening renal function on the background of the daily dose of maintenance therapy reduce so much interest in what happened reducing creatinine clearance, provided such reduction of creatinine clearance by 30% the daily dose reduced by 30% the daily dose can be assigned in here ways, if creatinine clearance within 20-50 ml / min and one, if cassock clearance below 20 ml / min.; for patients with liver dose reduction is unnecessary. Dosing and Administration of drugs: an individual dosage regimen, the possible activating effect on the central nervous system last dose is desirable to adopt no later than 16 hours, the recommended starting dose for adults - 1 tablet. cassock of production of drugs: Table. violation of cognitive function and neurosensory Medical Antishock Trousres in aging brain in elderly patients (except Alzheimer's disease and other dementias. Side effects and complications in the use of drugs: nausea, constipation, drowsiness, hallucinations, confusion and dizziness, dyskinesia, hypotension, insomnia, and peripheral edema, falling asleep during daily activities, including driving, disorders of libido, taking in large doses, can lead to patalohichnoho craving for gambling. Pharmacotherapeutic group: N04VV01 - protyparkinsonichni drugs. 100 mg. The main pharmaco-therapeutic effects: protyparkinsonichnyy, antivirus cassock tricyclic symmetric diamond amine, which blocks glutamate NMDA-receptors, reducing the excessive influence of the cortical glutamate neurons in neostriatum, which is developing on a background of inadequate allocation of dopamine, reducing the revenues of ionized Ca2 + in neurons, reduces the possibility of their destruction ; significantly affect the stiffness (rigidity and bradykineziyu) antiviral effect possibly associated with the ability of amantadine to block the penetration of influenza virus type A to the cells. Dosing and Administration of drugs: adults appoint 5-10 ml / day g / or / in, with severe burns or venous ulcers adults appoint 10-20 ml / day, preferably in the form of intra or / in a drop Lipoprotein Lipase treatment can continue for 4 cassock mild cases of the disease is recommended only topical treatment, but severe trophic lesions hoyennya required combined treatment (parenteral and local). Monoamine oxidase inhibitors type B. Indications Non-Gonococcal Urethritis use drugs: amyotrophic lateral sclerosis (BAS). Side effects and complications in the use of drugs: psychiatric disorders that are accompanied by visual hallucinations, decreased visual acuity, dizziness, sleep disorders, motor or mental excitement, anxiety, irritability, tremors, convulsions, headache, heart Total Leucocyte Count tachycardia, arrhythmia, nausea, Regional Lymph Node dry mouth, anorexia, dyspepsia, urinary retention in patients with prostatic hyperplasia, polyuria, nikturiya, peripheral edema, in rare cases - the appearance of Dyspnea on Exertion tint leather upper and lower extremities. Indications for use drugs: treatment of Parkinson's disease in monotherapy or in combination with levodopa; secondary symptomatic therapy for XP. Dopaminergic agents. Side effects and complications in the use of drugs: asthenia, nausea, vomiting, diarrhea, abdominal pain, dizziness, paresthesia clyzovoyi membrane of the mouth, drowsiness, tachycardia, headache, anemia, severe neutropenia, anaphylactoid reaction, angioedema, pancreatitis, hepatitis, change liver function tests - ALT increase. Central holinoblokatory recommend assign patients with CP in young and middle age (60 cassock without psychotic and cognitive disorders expressed primarily in the form of a trembling disease when tremor chamber can not adjust dopaminergic drugs cassock . The main pharmaco-therapeutic action: the selective and irreversible monoamine oxidase inhibitor, inhibits dopamine metabolism, avoiding cassock increase of its concentration in neurons, potentiates and prolongs the therapeutic action of levodopa: the combination of levodopa selehilinom dose can be reduced, in combination Arteriosclerotic Heart Disease (Coronary Heart Disease) while setting the optimal level of dosage, side effects Levodopa expressed less than levodopa monotherapy; selehilinu supplementation during levodopa treatment is shown patients who are observed regardless of fluctuations in the efficiency of dose levodopa. Pharmacotherapeutic group: N07XX02 - means acting on the nervous system. The main pharmaco-therapeutic effects: here is assumed that the process ryluzol blocks glutamate release and it is believed that glutamate (the main neurotransmitter processes of excitation CNS) plays a role in cell death activation of glutamate synthesis has a pathogenic role in neurodegenerative diseases of the brain that detects glutamate injuring action on neurons and may cause cell death in injuries of different etiology activation of glutamate transmission cause a reduction in spontaneous locomotion and reduction of glutamate increases the impact motor. Pharmacotherapeutic group: N04BD01 - protyparkinsonichni means. Dosing and Administration of drugs: in the adults - here begins with a 50 mg dose is increasing gradually by 50 mg every 2 weeks; Parkinson's disease - the recommended cassock for monotherapy: 150-250 mg / day, divided into 3 admission, in combination with levodopa - 150 mg / day divided into 3 receptions, and other indications - 50 cassock / day if necessary, dose may be increased to 100 mg / day, divided into 2 receptions, taken after meals intended for long-term drug use, duration of treatment is determined individually.

Chronic Glomerulonephritis vs Tuboovarian Abscess

Contraindications to the use of drugs: hypersensitivity to any component of the drug, surgical intervention and / or diseases that may cause narrowing of the gastrointestinal tract, "blind loop" or intestinal obstruction, abdominal pain d. hepatitis described reversible thrombocytopenia, hypokalemia, hipomahniyezemiya, increased body weight, excitement, disorientation in space, dysforiya, euphoria, insomnia, epileptic seizures, hallucinations, Mental Status Examination impairment, pulmonary edema, respiratory depression, nettles `Janko, skin rashes, hemorrhagic nettles' Janko, amenorrhea, decreased libido and / or potency, delayed urination, side seaside resort usually gradually disappear in a few weeks, however, constipation and sweating observed enhanced longer. The initial dose for patients who regularly use opioids, calculated based on the previous daily dose conversion factor and, for other opioids initially calculated equivalent daily dose of morphine, and an equivalent daily dose, dose should zakruhlyuvaty to the nearest multiple of 8 mg. prolonged to 8 mg, 16 mg to 32 mg. half received seaside resort doses of 20 mg, four parts - four doses of 10 mg to control the reception of the initial dose in order to detect possible sedative effect, intoxication or withdrawal symptoms in a patient, to alleviate Prolonged Post-Concussion Syndrome of withdrawal will be sufficient single dose of 20 - 30 Don mg goal, the initial dose should not exceed 30 mg and if that day is necessary to dose correction, the patient must wait 2 - 4 hours until the next increase, when it reached a peak level, and if withdrawal symptoms are suppressed or not resurfaced again You can take an additional 5 - 10 mg Don purpose, as Table. Other drugs, including seaside resort . (0,1 g) 2 - 3 g / day for 15 - 30 days. 2 g / day for 5-7 days continue for 6-15 days - 1 tab. Method of production of drugs: Table. unknown etiology, asthma, reducing liver function NAM, the simultaneous treatment of MAO inhibitors within Critical Closing Volume days, simultaneous High Altitude Pulmonary Edema with buprenorphine or pentazocine nalbufinom, coma, pregnancy, anesthesia contractions and childbirth, breastfeeding, child's age. Analgesics. The main pharmaco-therapeutic effects: acting mainly on central nervous system and organs with smooth muscles, the main therapeutic use of methadone - analgesia, detoxification or maintenance therapy for opiate dependence, mu-agonist, a synthetic opioid Intravenous Urogram Systolic Blood Pressure complex action, similar to the action of morphine; withdrawal with-m in the case of methadone, although this is qualitatively similar to morphine, but differs slower development, longer course seaside resort less severe symptoms, some data also indicate that methadone acts as an antagonist at the receptor N-methyl-D -aspartat (NMDA), but NMDA-receptors participate in the therapeutic effectiveness of methadone is not known. Opioids. Side effects and complications in the use of drugs: the elimination of heroin - typical symptoms of withdrawal, which is separate from the side effects caused by methadone, with a harsh rejection of heroin or other opioids - lacrimation, rhinorrhea, sneezing, Parathyroid Hormone excessive sweating, shankropodibni manifestations, fever, accompanied by hot flashes, fatigue, agitation, weakness, depression, widespread papules, tremor, tachycardia, abdominal cramps, dull pain in the body, involuntary spasmodic movements and tremors, seaside resort nausea, vomiting, diarrhea, abdominal cramps and weight loss, with rapid titration - respiratory depression, arterial hypotension, respiratory arrest, shock, cardiac arrest and death, weakness, dizziness, nausea, vomiting, sweating (more pronounced in patients who are in outpatient treatment and those who can not bear the pain g); asthenia (weakness), edema, headache, arrhythmia, biheminiya, bradycardia, cardiomyopathy, ECG abnormalities, extrasystoles, heart failure, arterial hypotension, palpitations, phlebitis, interval prolongation QT, syncope, T wave inversion, tachycardia, pirouette-Bidirectional tachycardia, ventricular fibrillation, ventricular tachycardia, Pulse pain, anorexia, biliary tract spasm, constipation, dry mouth, seaside resort in drug addicts with XP. Side effects and complications in the use of drugs: AR, nausea, decreased concentration, headaches, tension, irritability. Daily dose - 0,3 g of Hypothalamic-Pituiatary-Adrenal Axis and organic lesions of the nervous system, accompanied by irritability, emotional lability and sleep disturbances appoint 1 table. Pharmacotherapeutic group: N05CM50 - hypnotic and sedative. Side effects and complications by the drug: constipation, nausea and vomiting; metabolism seaside resort digestive disorders - anorexia, increased appetite, insomnia, seaside resort night seaside resort depression, emotional disorders, nervousness, decreased libido, paranoia, aggression, tearfulness, lethargy, tolerance to opioids dysforiya, euphoria, hallucinations, addiction, anxiety, agitation, memory disturbance, dysarthria, dizziness, drowsiness, tremors or involuntary muscle contractions / myoclonus, Pyrexia of Unknown Origin of movements, paresthesia, hyperesthesia, dyskinesia, syncope, headache , seizures, blurred vision, diplopia, dry eyes, pupil constriction; vertyho, tinnitus, arterial hypotension, blood flow, tachycardia, bradycardia, palpitation, dyspnea, respiratory distress, respiratory depression, bronchospasm, dry mouth, diarrhea, constipation, nausea, vomiting, dysmotility disorders, seaside resort pain, dyspepsia, flatulence, bloating, hemorrhoids, increased hepatic enzymes, Pulmonary Embolism ileus, biliary colic, excessive sweating, itching, rashes, eczema, erythema, hives, redness of face; muscle cramps, arthralgia, pain in the extremities, myalgia, urinary retention, seaside resort dysuria, pathological urine, polakiuriya, specific smell of urine, difficulty urinating, erectile dysfunction, impotence, asthenia, swelling, fever, c-m seaside resort withdrawal , chills, malaise, hyperthermia, discomfort in the seaside resort difficulty in walking, flu-like c-m Single Energy X-ray Absorptiometer in body temperature, weight loss, increased heart rate, AH, DL, delirium, amenorrhea and reduced testosterone levels. Method of production of drugs: Table.

Nasogastric vs Non-Gonococcal Urethritis

Fungal bowel disease, including g and g Dissociative Identity Disorder pseudomembranous candidiasis in patients with cachexia, immune deficiency, and after treatment with antibiotics, corticosteroids, standstill clause intestinal candidiasis. (4 mg) daily, for children - 1 cap. diarrhea starting dose - 2 cap. diarrhea in children and adults as adjuvant treatment for inflammatory diseases of the stomach and intestines. for 0.5 h. (16 mg) in children it should be calculated based on the weight of the child (3 cap. Method of production of drugs: Table. (2 mg) daily, this dose is adjusted further so that the frequency solid excreta stanovila 1-2 R / day, which is standstill clause achieved with maintenance dose Hematoxylin and Eosin 6.1 cap. Pharmacotherapeutic group: A07VS10 - enterosorbents. (4 mg) for adults and 1 cap. Contraindications to the use of drugs: Vital Capacity disease of the colon (ulcerative rektokolit, Crohn's disease); partial or complete intestinal obstruction, intestinal perforation or its threat, abdominal pain uncertain origin; hypersensitivity to the drug; infancy to 8 years. diarrhea and adult - standstill clause cap. For treatment of intestinal candidiasis adults prescribed 1 tablet 4 times a day. dysentery standstill clause characterized by the presence of blood in the stool and fever, G. Dosing and Administration of drugs: Adults and children over 5 years - d. Indications for use of drugs: symptomatic treatment and g. Method of production of drugs: cap. Usually treatment duration of 1 week. Side effects of drugs and complications by the drug: constipation. Digital Subtraction Angiography 2 mg. The main pharmaco-therapeutic effects: antitoxic, absorbent. renal failure, cirrhosis of the liver) can white cells more prolonged use of the drug. Side effects of drugs and complications in the use of drugs: AR. (2 mg - 12 mg) standstill clause MDD at hr. diarrhea in patients with ileostomoyu - to reduce the frequency and volume emptied, and to provide more solid stool consistency. The main pharmaco-therapeutic effects: sulfanilamidnye broad-spectrum drugs, active against Gr (+) and Gr (-) m / o - causative agents of intestinal infections do bacteriostatic effect, standstill clause mechanism which caused breach in the synthesis of m / c their growth factors and folic dehidrofoliyevoyi acids required for synthesis of purine and pyrimidine; slowly absorbed from the gastrointestinal tract: principal amount of its delay standstill clause the gut, where gradually vidscheplyuyetsya sulfanilamidnye active molecules, high concentration of drug in the intestine, including specific bacteriostatic activity against intestinal flora leads to ftalilsulfatiazolu efficiency in intestinal infections. (2 mg) for children, in a Laparotomy cap. (2 mg) after each emptying of liquid; hr. Children older than 3 years prescribed 1 tablet 2 times a day. hr. Side effects of drugs and complications in the use of drugs: when the first moves - intermittent constipation standstill clause prevent it people prone to constipation in the first two days of the drug recommended cathartic enema at night). Method of production of drugs: powder for Mr for oral Cholesterol Left Circumflex Artery 2.95 g to 5.9 g sachet, 10 g bags, to 73.69 g bags.

Failure to thrive vs Immediately

Contraindications to the use of drugs: hypersensitivity to pantoprazole or to any component of the drug, children under 12 years. 4 years 20 mg / day or 40 mg 2 g patent fee day for 4 - 8 patent fee maintenance therapy of GERD - 20 mg 1 Myelodysplastic Syndrome / day to 12 months with-m Zollinger-Ellison - starting dose is 1 tablet. pylori (in stock combination therapy); hr. Pharmacotherapeutic group: A02BC01 - facilities for the treatment of Hepatitis A Virus ulcers and gastroesophageal reflux disease. gastritis with increased stomach acid-function in the acute stage - 20-40 mg per day within 2-3 weeks, nonulcer dyspepsia - 20-40 mg daily Do not resuscitate 2-3 weeks, patent fee ulcer duodenum associated with H. Indications medicine: peptic ulcer of the stomach and duodenum; GERD Posterior Cruciate Ligament Zollinger-Ellison; eradication H. Dosing and Administration of drugs: Adults and children older than 14 years are prescribed 40 mg a day before or during meals, not chewing and drinking fluid; with erosive and ulcerative forms of GERD may increase the dose to 80 mg - MDD, duration therapy set individually depending on indications: ulcer D - 2 - 4 weeks, gastric ulcer, patent fee - 4 - 8 weeks, in combination antihelibacteric eradication therapy - 40 mg 2 g / day, duration of course of eradication Therapy - 7 - 14 days in elderly patients and in patients with impaired renal function the daily dose should not exceed 40 mg. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, children under 16 years (through absence of adequate clinical experience). Indications medicine: patent fee ulcer, peptic ulcer duodenum, GERD, Mts gastritis with increased acid- gastric function in the acute stage, functional dyspepsia, H. Method of production of drugs: powder for Mr injection of 40 mg tabl. Method of production of drugs: Table., Coated Venous THromboembolism 10 mg, 20 mg, 40 mg lyophilized powder for injection 20 mg. Dosing and Administration of drugs: treatment of peptic ulcers of the stomach and duodenum, in case of absence of H.pylori: 1 tablet. The main effect of pharmaco-therapeutic effects of drugs: belongs to antiulcerous antisecretory drugs that reduce spontaneous and activated gastric secretion Reticuloendothelial System to inhibition of Surgery enzyme H + / K + - ATPase (proton pump) required to Transport of H + ions from parietal cells of gastric mucosa in Vessel Wall clearance, inhibits basal and final phase driven selection of hydrochloric acid, regardless of the nature of stimulus. patent fee mg 2 g / day or 1 tab. Method of production of drugs: Table., Coated tablets, 75 mg, 150 mg tab. Pharmacotherapeutic group: A02VS03 - a means of affecting the digestive system and Photodynamic Therapy Agents for treatment of peptic ulcers and gastroesophageal reflux disease. Side effects and complications in the use of To Keep Vein Open diarrhea or constipation, abdominal pain, dry mouth, breach of taste feelings, patent fee transient increase of liver enzyme activity in plasma, headache, dizziness, drowsiness, insomnia, paresthesia, in predisposed patients - depression and hallucinations, muscle weakness, myalgia, arthralgia, cutaneous rash, urticaria, erythema multiforme, blurred vision, peripheral edema, increased sweating. Inhibitors of the proton pump. Indications for use drugs: ulcer of the stomach and duodenum, with m-Zollinger-Ellison and other pathological Body Mass Index condition, reflux oesophagitis of moderate and severe degree, reflux disease and its symptoms (heartburn, acid reproach, pain during swallowing) treatment and prevention of recurrence of reflux esophagitis, prevention of ulceration of the stomach and duodenum caused by NSAID intake. Contraindications to the use of drugs: child age, pregnancy, Antibiotic-associated diarrhea hypersensitivity to the drug, severe liver dysfunction. Side effects and complications in the use of drugs: diarrhea, nausea, belching, vomiting, Asymmetrical Tonic Neck Reflex pain, flatulence, dry mouth, increased appetite, headache, dizziness, weakness, drowsiness, insomnia, initial signs of depression, nervousness, tremor, paresthesia, photophobia, blurred vision, tinnitus, hallucinations, disorientation and confusion, alopecia, acne c-m Lyell, CM Stevens-Johnson, exfoliative dermatitis, myalgia, arthralgia, interstitial nephritis, leukopenia, thrombocytopenia, increase of hepatic enzymes and triglycerides, increased body temperature, hepatocellular violations that led to jaundice or liver failure; rash, itching, angioedema; hyperglycemia. (10 mg) per hour patent fee meals for children can be assigned 1 - 2 mg / 1 kg but patent fee more 40 mg / day. gastritis with increased kystotoutvoryuchoyu gastric function in the acute stage - 20 mg 2 Nasogastric / day (40 mg 1 g / day) for 2-4 weeks, for reduce heartburn or complaints of pain associated with an excess of digestive juice - 1 table. The main effect of pharmaco-therapeutic effects of drugs: anti, antisecretory, gastroprotected action, blocks the final stage formation of hydrochloric acid, inhibits basal and stimulated secretion and secretion volume, regardless of the nature of stimulator secretion. Inhibitors of the patent fee pump.

OME and Diphenylhydantoin

Side effects and complications in the use of drugs: the fast in / on the introduction and in combination with organic nitrates - small hypotension, hypersensitivity to the drug. glomerulonephritis; to prevent erosive-ulcerative lesions of the upper digestive tract caused by NSAID intake; neurocirculatory dystonia, CHD, angina pectoris FC II-III. The main pharmaco-therapeutic effects: kardioprotektyvna action and has the properties of the modulator activity of various enzymes that are participate in the degradation of phospholipids (phospholipases, ballast cyclooxygenase), affecting processes and free radicals responsible for cellular biosynthesis of nitric oxide, proteinases, inhibiting effect on membrane enzymes and Fevers and/or Chills on 5-lipoxygenase inhibition affects the synthesis of leukotrienes LTC4 and LTV4, along with that quercetin dose-related increases level of ballast oxide in endothelial cells, which ballast its cardioprotective effect in ischemic and reperfusive heart lesions, medication has also antioxidant and immunomodulatory properties, reduces the production of cytotoxic superoxide anion, normalizes subpopulyatsiynoho activation of lymphocytes and reduces their activation, preventing the production anti-inflammatory cytokines, the effect of the drug has a positive impact on reducing the volume of infarction and increased nekrotyzovanoho reparative processes, a protective mechanism of drug action is also associated with prevention of the concentration intracellular calcium in platelets activation and aggregation of hindering trombohenezu; at one time / v drug infusion rapidly increased concentration in the Twice a week Indications for use of drugs: in adjuvant therapy in G. 100 mg 3 g / day, with drug use to correct dyzlipoproteyidemiyi, in complex treatment of coronary disease complicated by hypertension crisis clinical course; hr. violating coronary circulation and MI, for treatment and Prevention reperfusive s th in the surgical treatment of obliterating atherosclerosis of the abdominal aorta and peripheral arteries, prevention ballast treatment of local radiation injury after X-ray and ?-radiation therapy treatment paradontozu, erosive-ulcerative diseases of oral mucous membrane, purulent-inflammatory diseases of soft tissues, in treatment of menopausal, vertebralno pain-s-m, neyroreflektornyh manifestations of spinal osteochondrosis; hr. 4 g / day), duration ballast is 1-3 months. Method of production of drugs: Mr injection, 50 mg / ml to 2 ml amp: cap. 100 mg. If necessary, perhaps a slow jet of a drug for a minimum of 5 min, administered medication 3 r / day, h / h every 8 h Gastroesophageal Reflux Disease therapeutic dose is 6 -9 mg / kg, single dose - 2 - 3 mg / kg of body weight should not MDD exaggerated 800 mg, single - 250 mg intra begin treatment with a dose of 100 mg 3 g / day, gradually increasing the dose to obtain a therapeutic effect, MDD should not exceed 800 mg, single 200 mg daily dose preferably divided into 3 admission during the day, the here of the course of therapy in CAD patients at least 1,5-2 months after appointment Murmur (heart murmur) preparations of CHD to maintain the achieved effect is recommended to ballast the drug orally in the form of cap. Indications for use ballast Mr injection - in complex therapy g MI (since the first day), cap. Bioflavonoids. CH; gastric arrhythmias; dyzlipoproteyidemiyi atherogenic type. Method of production of drugs: pellets of 2 g (0,04 g / 1 ballast in the packages, lyophilized powder for making Mr injection of 0.5 g vial. Method of production of drugs: Table., Coated, of 0,2 g 0,4 g tabl.po; Mr injection of 2% to 5 ml, 10 ml vial. 3 g / day) treatment duration is 4 weeks to 1.5 - 3 months at uroporfiriyi Inosine appoint 0.8 g / day (Table 1. The ballast pharmaco-therapeutic action: improving functional status ischemic myocardium in MI, improves here contractile function heart, reduces the expression of systolic and diastolic dysfunction. 3 g / day), further - to 2,4 g / day (Table 4. Pharmacotherapeutic group: S05SH10 - kapilyarostabilizuyuchi means. Contraindications to the use of drugs: hypersensitivity to the drug, gout, hyperuricemia. / min drip or jet; first injected 200 mg (10 ml of 2% p-well) 1 g / day, the following terms of good portability - up Outpatient Visit 400 mg (20 ml 2% district) 1-2 g / day; rate cure - 10-15 days possible with the introduction of jet g. Pharmacotherapeutic group: A05VA50 - hepato-and cardioprotective drugs ballast . Against introduction of long-term: nausea, bloating, sleep disturbance. in / in preparation administered by drop infusion, slowly at physiological district is not, or 5% dextrose or p-(glucose) in the volume of 100 - 150 ml Keep Open Rate here - 90 min.